Interní Med. 2011; 13(5): 205-208

Contrast - induced nephropathy

MUDr.Jan Svojanovský, doc.MUDr.Kamil Ševela, CSc., prof.MUDr.Miroslav Souček, CSc.
II. interní klinika FN u sv. Anny v Brně a LF MU, Brno

Contrast-induced nephropathy (CIN) is an iatrogenic renal impairment developing after administration of contrast medium (CM). The

incidence of this condition has recently increased with the increasing use of diagnostic and interventional radiological procedures. The

pathogenesis of CIN involves a wide range of processes affecting the renal parenchyma, such as intrarenal vasoconstriction and medullary

ischemia, direct tubulotoxic effect of CM, oxidative stress and apoptosis. There are numerous factors that increase the risk of developing

CIN, particularly preexisting renal damage, diabetes mellitus, medications and the type and amount of CM. Measures preventing

the development of CIN primarily include renal function assessment, proper hydration, discontinuation of risk-related medication and

minimizing the amount of CM. Also considered is preventive administration of acetylcysteine or theophylline.

Keywords: nephropathy, contrast medium, risk factors, preventive measures

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svojanovský J, Ševela K, Souček M. Contrast - induced nephropathy. Interní Med. 2011;13(5):205-208.
Download citation

References

  1. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. Am J Roentgenol 2003; 181: 1463-1471.
  2. Katzberg RW, Halley C. Contrast-induced nephrotoxicity: Clinical lansdscape. Kidney Int 2006; 69 (Suppl 100): S3-S7. Go to original source... Go to PubMed...
  3. Brendan J, Barrett MB, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386. Go to original source... Go to PubMed...
  4. Krusová D, Ševela K. Kontrastní látkou indukovaná nefropatie. Vnitř Lék 2006; 9:805-811.
  5. Kandzari DE, Rebeiz AG, Wang A, et al. Contrast nephropathy: an evidence-based approach to prevention. Am J Cardiovasc Drugs 2003; 3: 395-405. Go to original source... Go to PubMed...
  6. Bartolomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary interventions and a method for risk stratification. Am J Cardiol 2004; 93: 1515-1519. Go to original source... Go to PubMed...
  7. van Praet JT, de Vriese AS. Prevention of contrast-induced nephropathy: a critical review. Curr Opin Nephrol Hypertens 2007; 16: 336-347. Go to original source... Go to PubMed...
  8. Rychlík I, Nehézová K, Ryšavá R. Nefrotoxicita kontrastních látek. Pokroky v oboru nefrologie 2008; 1:53-63.
  9. Kshirsargar AV, Poole C, Mottl A, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004; 15:761-767. Go to original source... Go to PubMed...
  10. Frank H, Werner D, Lorusso V, et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 2003; 60: 176-182. Go to original source... Go to PubMed...
  11. Marenzi G, Lauri G, Campodonico J, et al. Comparasion of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006; 119: 155-162. Go to original source... Go to PubMed...
  12. McCoullough PA, Stacul F, Davison Cl, et al. Overview. Am J Cardiol 2006; 98: 2-4. Go to original source...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.